Enzyme Regulation & Inhibition

Enzyme Function & Catalysis

• Enzymes are biological catalysts.
  • Primary role: speed up reactions by lowering the required activation energy (AE).
  • Formal statement: $E<em>a\,(\text{with enzyme}) < E</em>a\,(\text{without enzyme})$
  • Lower activation energy means reactant molecules reach the transition state more easily and the overall reaction rate increases.

The Cellular Need for Regulation

• Constantly producing and destroying enzymes is energetically expensive.
• Cells therefore regulate activity, not just abundance.
  • Temporarily switch enzymes “on” or “off” instead of synthesizing/degrading them each time.
  • Achieved mainly through enzyme inhibitors.

Types of Enzyme Inhibitors

1. Competitive Inhibitors

• Bind directly in the active site (same place the substrate normally occupies).
• Physical blockage prevents substrate access.
• Enzyme is effectively inactive while inhibitor is bound.
• Inhibition can be overcome by adding more substrate (they compete).

2. Non-competitive (Allosteric) Inhibitors

• Bind to a different site (allosteric site) on the enzyme.
• Trigger a conformational change that alters the shape of the active site.
• Substrate no longer fits; catalysis stops.
• Cannot be overcome simply by adding more substrate because the active site itself is distorted.

Comparison Summary

• Location of binding: active site vs allosteric site.
• Mechanism: steric blockage vs shape change.
• Substrate concentration effect: can out-compete competitive inhibitors, not non-competitive ones.

Feedback Inhibition (End-Product Inhibition)

• Essential for fine-tuning entire metabolic pathways.
• When the final product accumulates beyond need, it acts as an inhibitor—typically on the first enzyme of the pathway.
  • Prevents unnecessary consumption of substrates & energy.
• Example visual (described verbally):
  1. Reaction 1 → Reaction 2 → Reaction 3.
  2. Product of Reaction 3 builds up.
  3. Product binds enzyme 1, halting Reaction 1.
• Provides quick, reversible shut-down and restart capability.

Enzyme Inhibitors in Medicine (Beneficial Uses)

• Many pharmaceuticals exploit reversible inhibition.
• Illustrative list:
  • Ibuprofen (NSAID): inhibits enzymes that synthesize prostaglandins ⇒ reduced inflammation & pain.
  • Blood-pressure medications: e.g., ACE inhibitors block angiotensin-converting enzyme, lowering blood pressure.
  • Antidepressants: MAO inhibitors prevent breakdown of neurotransmitters.
  • Cancer therapeutics: certain drugs inhibit kinases or other enzymes vital for tumor growth.
  • Antivirals: e.g., HIV protease inhibitors block viral protein processing.
  • Antibiotics (e.g., Penicillin): irreversibly inhibit bacterial transpeptidase enzymes needed for cell-wall synthesis ⇒ bacterial lysis & death.

Harmful Inhibitors & Chemical Warfare

• Pesticides & nerve agents are also enzyme inhibitors but with much stronger, often irreversible actions.
• Mechanism: form covalent bonds with active-site residues → permanent inactivation.
  • Irreversible inhibition: $E_{\text{active}} + I \longrightarrow E{\text{–}}I \;(\text{covalent, non-reversible})$
  • Enzyme cannot be regenerated; cellular pathways fail, can be lethal.
• Ethical concern: same basic chemistry used for therapy can be weaponized.

Key Concepts Recap

• Activation Energy ($E_a$): energy barrier lowered by enzymes.
• Active Site: catalytic pocket where substrates bind.
• Allosteric Site: separate site influencing active‐site shape/function.
• Competitive vs Non-competitive Inhibition: distinguish by binding site, reversibility, substrate competition.
• Feedback Inhibition: self-regulating loop using pathway product as inhibitor.
• Irreversible Inhibitors: form covalent bonds → enzyme permanently lost.

Practical & Philosophical Implications

• Regulation ensures metabolic efficiency, prevents waste, and maintains homeostasis.
• Drug design leverages detailed knowledge of enzyme structure & inhibition types.
• Balancing benefit (medicine) vs harm (pesticides/warfare agents) highlights ethical responsibility in biochemical research.

Suggested Study Connections

• Link these concepts back to earlier chapters on thermodynamics (ΔG, reaction spontaneity) and metabolism (catabolic vs anabolic pathways).
• Remember enzyme-substrate complexes obey Michaelis-Menten kinetics, where competitive inhibition raises apparent $K<em>m$ while non-competitive lowers $V</em>{max}$ (not covered in this short lecture but essential background).